221
Generic Name: sitagliptin
Pill imprint 221 has been identified as Januvia 25 mg.
Januvia is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy.
Januvia 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Januvia Images
- Generic Name:
- sitagliptin
- Imprint:
-
221
- Strength:
- 25 mg
- Color:
- Pink
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
ferric oxide red
sodium stearyl fumarate
magnesium silicate
titanium dioxide
ferric oxide yellow
- Drug Class:
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Merck & Company Inc.
- National Drug Code (NDC):
- 00006-0221
Advertisement
More Januvia resources
Search Again
